PCSANasdaq United States
Market cap
$8.549 M
$2.57 +11.74%
Close of 7 Aug 2026
Revenue
—
Not reported
Earnings
$13.6M
#1988 by earnings
Shares outstanding
2,660,039
Latest filing cover page
P/E ratio
0.6
Cap ÷ net income
Where these numbers come from
Share counts and financials for Processa Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.